We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Clinical Results Presented for Urine-Based High-Risk HPV Assay

By LabMedica International staff writers
Posted on 24 Sep 2014
Print article
Image: Histopathology of cervical intraepithelial neoplasia (CIN3) showing severe dysplasia that spans more than 2/3 of the epithelium, and may involve the full thickness. This lesion may sometimes also be referred to as cervical carcinoma in situ (Photo courtesy of KGH/Wikipedia Commons).
Image: Histopathology of cervical intraepithelial neoplasia (CIN3) showing severe dysplasia that spans more than 2/3 of the epithelium, and may involve the full thickness. This lesion may sometimes also be referred to as cervical carcinoma in situ (Photo courtesy of KGH/Wikipedia Commons).
Two pilot studies have demonstrated that a urine-based assay for the detection of high-risk human papillomavirus (HR-HPV) had high sensitivity for identifying women with high grade cervical intraepithelial neoplasia (CIN2/3).

Assay performance was comparable to traditional HPV testing with commercially available tests in patient-matched cervical samples and in one of these studies, urine collection has been examined to establish standardization of urine as a clinical specimen for high-risk HPV testing.

Scientists at the University of Oklahoma Health Sciences Center (Oklahoma City, OK, USA) studied a total of 72 women with abnormal cervical cancer screening results that had been referred to a colposcopy clinic. Urine samples had been collected from each patient prior to undergoing a pelvic exam to obtain a cervical sample. In urine samples, the high-risk HPV assay was superior to a commercially available HPV test for the identification of high-risk HPV positive women with CIN2/3. When comparing patient-matched urine samples with cervical specimens for the identification of high-risk HPV positive women with CIN2/3, the HR-HPV assay was comparable to traditional HPV testing from cervical specimens.

The high-risk HPV urine assay is a product of Trovagene, Inc. (San Diego, CA, USA) and was used in another study conducted at University of North Carolina (Chapel Hill, USA). A total of 37 women referred to a colposcopy clinic due to abnormal cervical cell cytology or persistent HPV infections were evaluated. The detection rate of high-risk HPV from a urine sample by the HR-HPV assay was not affected by the time of day when the urine sample was collected, or whether an initial versus mid-stream urine sample was used. Additionally, this study showed that women preferred providing a urine sample over brush self-collection of a cervical sample for HPV testing. Urine samples are clinically practical and preferred. Finally, a comparison of patient-matched urine samples versus cervical samples for the identification of high-risk HPV positive women with CIN2/3 found that the Trovagene HR-HPV assay, when using a urine sample, was comparable to traditional HPV testing of cervical samples using a commercially available kit.

Jennifer S. Smith, PhD, MPH, a principal investigator of the study, said, “Trovagene's urine-based high-risk HPV assay showed high sensitivity for the detection of high-grade cervical lesions among this group of colposcopy patients from North Carolina. Given women's stated preference for urine-based sampling, these results are encouraging for larger validation studies to be conducted in non-colposcopy populations, particularly because urine-based sampling is likely to reduce both logistical and acceptability barriers when screening hard-to-reach populations.” The studies were presented at the 29th International Papillomavirus (IPV) Conference held August 21–25 2014, in Seattle (WA, USA).

Related Links:

University of Oklahoma Health Sciences Center
Trovagene, Inc. 
University of North Carolina 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.